{
    "Trade/Device Name(s)": [
        "OMNis Health Embrace Glucose Control Solution"
    ],
    "Submitter Information": "Bionostics, Inc.",
    "510(k) Number": "K091914",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090043"
    ],
    "Regulatory Class": "Class I (reserved)",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "September 23, 2009",
    "Summary Letter Received Date": "September 24, 2009",
    "Submission Date": "5 October 2009",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "Plastic vial"
    ],
    "Instrument(s)/Platform(s)": [
        "OMNis Health Embrace blood glucose test systems"
    ],
    "Method(s)/Technology(ies)": [
        "Viscosity-adjusted aqueous solution"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for OMNis Health Embrace Glucose Control Solution as a control material for verifying OMNis Health Embrace blood glucose test system performance",
    "Indications for Use Summary": "Intended to assess performance of OMNis Health Embrace blood glucose test systems for use by healthcare professionals and people with diabetes mellitus at home",
    "fda_folder": "Clinical Chemistry"
}